Mohammed et al. lay forward a plausible hypothesis for the prognostic impact of CD138+ TILs based on these facts, whereby a large CD138+ subpopulation is suggested to suppress T-cell response or to promote tumour progression by nurturing an inflammatory microenvironment [30]. The gene discussed is SDC1; the disease is neoplasm.